Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 18Carcinoma, Non-Small-Cell Lung 6Glioma 5Brain Neoplasms 5Head and Neck Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Astrocytoma 3Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pain 2Lung Neoplasms 2Gliosarcoma 2Central Nervous System Neoplasms 2Bone Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomatitis 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Nervous System Diseases 1Neoplasms by Site 1

Interventions

Fibroblast Growth Factor 7 9avasopasem manganese 4Cisplatin 4Radiotherapy, Intensity-Modulated 3Injections 3golotimod 2Saline Solution 2Radiotherapy 2RRx-001 2Mouthwashes 2Low-Level Light Therapy 2FGF20 protein, human 2Drug Therapy 2Benzydamine 2meclocycline 1hydrated silica gel-based toothpaste 1dusquetide 1cobiprostone 1clazakizumab 1brilacidin 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Whole-Body Irradiation 1Water 1Transplantation Conditioning 1Standard of Care 1Radiation 1Prednisolone 1Niacinamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Stomatitis × Radiation × Clear all
NCT02542215 2019-12-02

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Mallinckrodt

Phase 2 Terminated
47 enrolled

Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡